Group name
Xi
BCR
20 (24.4)
p-value
1
remark
Biochemical recurrence, n (%)
Complications or other prognosis
17 (20.7)
p-value
0.717
remark
Postoperative complications, n (%), Clavien < 3
Other Outcomes
84,740.7 (16,531.2)
p-value
0.003
remark
Total cost of hospitalization, mean (SD), 楼
Follow Up Time
8.7 (1.7) mon